# SARCULATOR > Physician tool for predicting sarcoma patient survival rates. (iPhone/iPad app by DIGITAL FOREST SRL.) - Source: https://appshunter.io/ios/app/sarculator/id1052119173 (this page in markdown: same URL + `.md`) - Developer: [DIGITAL FOREST SRL](https://appshunter.io/developer/581246108) - Category: Medical - Price: Free - Rating: 4.33/5 from 3 App Store ratings - Age rating: 12+ - Requires: iOS 13.0 · 26 MB - Languages: English - Released: 2015-11-13 - Data updated: 2026-06-01 - Monetization: free - User reviews in markdown: https://appshunter.io/ios/app/sarculator/id1052119173/reviews.md ## What is SARCULATOR? This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients. ## Key features - Predictive models for sarcoma patients - Estimates 5-year overall survival - Estimates 5-year disease-free survival - Estimates 10-year overall survival - Estimates cumulative incidence of distant metastasis - Informative tool for physicians ## Frequently asked questions about SARCULATOR ### What is SARCULATOR used for? SARCULATOR is an informative tool for physicians to improve their predictive capability regarding survival rates for patients with retroperitoneal and extremity sarcomas. ### Does SARCULATOR make clinical decisions? No, SARCULATOR is not meant to make clinical decisions. Its clinical usefulness has not been tested, and it serves solely as an informative tool for physicians. ### What types of predictions can SARCULATOR provide? SARCULATOR can provide predictions for 5-year overall survival and disease-free survival in primary resected retroperitoneal sarcoma patients, as well as 5- and 10-year overall survival and cumulative incidence of distant metastasis in primary resected extremity sarcoma patients. ### Is SARCULATOR available on Android devices? Based on the provided data, SARCULATOR is supported on iPhone, iPad, and iPod. Information regarding Android compatibility is not available. ### What is the age rating for SARCULATOR? SARCULATOR has an age rating of 12+, indicating it is suitable for users aged 12 and older. ### How often is SARCULATOR updated? The latest version of SARCULATOR is 3.0.2, which was last updated on May 1, 2026. This suggests a potentially infrequent update cycle. ### What is the user sentiment for SARCULATOR? SARCULATOR has a rating of 4.3 stars from 3 ratings, indicating generally positive user sentiment among its limited reviewer base. ### Does SARCULATOR have ads? No, SARCULATOR does not contain advertisements, as indicated by the 'hasAds' flag being false. ## Version history (last 5 releases) ### 3.0.2 — 2026-05-01 Sarculator now includes BayeSarc, a new Bayesian sequential-learning model for prognosis prediction in patients with extremity soft-tissue sarcoma. ### 2.2.1 — 2023-11-06 Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect. ### 2.2 — 2023-10-31 Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect. Aggiornamento: nuovo modello per pazienti con sarcomi primitivi del retroperitoneo che tiene in considerazione del miglioramento della prognosi osservata negli anni recenti e l’effetto del volume del centro. ### 2.1.2 — 2022-07-28 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. ### 2.1.1 — 2022-07-27 Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors. ## Apps similar to SARCULATOR | App | Rating | Price | Category | | --- | --- | --- | --- | | [ASCO Meetings](https://appshunter.io/ios/app/asco-meetings/id6473720764) | 5.0 (1) | Free | Medical | | [Physicians Cancer Chemotherapy](https://appshunter.io/ios/app/physicians-cancer-chemotherapy/id1361675468) | 4.8 (233) | Free | Medical | | [ASCO Member](https://appshunter.io/ios/app/asco-member/id6742142845) | — | Free | Medical | | [ESMO Interactive Guidelines](https://appshunter.io/ios/app/esmo-interactive-guidelines/id1037353712) | 4.8 (139) | Free | Medical | | [Tempus Provider](https://appshunter.io/ios/app/tempus-provider/id1323177746) | 5.0 (21) | Free | Medical | | [ESMO Events App](https://appshunter.io/ios/app/esmo-events-app/id908386555) | 4.2 (6) | Free | Medical | ## More apps by DIGITAL FOREST SRL - [Gruppo BPER - APP Eventi](https://appshunter.io/ios/app/gruppo-bper-app-eventi/id1180555395) - [DG TRAVEL](https://appshunter.io/ios/app/dg-travel/id6475873737) - [AIDP](https://appshunter.io/ios/app/aidp/id6740077098) - [MelaRisk](https://appshunter.io/ios/app/melarisk/id6741823940) All apps by DIGITAL FOREST SRL: https://appshunter.io/developer/581246108 --- *Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-01.*